Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. (2013)

First Author: Diffner E
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2012-07-446120

PubMed Identifier: 23327922

Publication URI: http://europepmc.org/abstract/MED/23327922

Type: Journal Article/Review

Volume: 121

Parent Publication: Blood

Issue: 12

ISSN: 0006-4971